2m 2m 2m 2m 2m 2m 2m
- $2.5BMarket Cap
- -22.95%1-Year Change
- Software - InfrastructureIndustry
CELLEBRITE-A (CLBT)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 37
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
3 Growth Stocks Worth $5,000 of Your Money -- Even in This Market
The article recommends three underappreciated growth stocks: Credo Technology (AI data center connectivity), Cellebrite (law enforcement digital evidence software), and TransMedics (organ transplant preservation technology). Each company is positioned in large, expanding markets with limited competition and strong fundamentals.
06/05/2026, 8:20 AM • The Motley Fool
Cellebrite Files its 2025 Annual Report on Form 20-F
Cellebrite (NASDAQ: CLBT), a global leader in AI-powered digital investigative and intelligence solutions, announced the filing of its 2025 Annual Report on Form 20-F with the SEC. The report is available on the company's investor relations website and the SEC's website.
03/04/2026, 8:30 AM • Benzinga
Portolan Capital increased its stake in Cellebrite by 1.4 million shares in Q3 2025, making it their 10th-largest holding. The investment firm appears confident in Cellebrite's digital intelligence solutions and potential for growth.
11/19/2025, 1:32 PM • The Motley Fool
Why Cellebrite Stock Is Skyrocketing Today
Cellebrite reported strong Q3 earnings, beating Wall Street expectations with $126.03 million in revenue and raising full-year guidance. The company saw nearly 18% year-over-year sales growth and anticipates further expansion through its pending Corellium acquisition.
11/13/2025, 1:21 PM • The Motley Fool
Cellebrite Begins Its Next Chapter
Cellebrite reported strong Q2 2025 performance with 18% year-over-year revenue growth, exceeded earnings expectations, and appointed Tom Hogan as permanent CEO. The company remains cautiously optimistic about future business prospects and potential acquisition of Corellium.
08/14/2025, 8:30 AM • The Motley Fool
Peers
Statistics
MoreInformation as of 06/22/2026
Company Profile
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
Key Executives
- Thomas E. Hogan
- Marcus Jewell
- Ronnen Armon
- David Nicholas Gee
- David Barter
Current Ownership Distribution
- Institutions1.3B (95.46%)
- Mutual Funds46.3M (3.37%)
- Insiders16.0M (1.17%)
- Other0 (0.00%)